Welcome!

SYS-CON UK Authors: Salvatore Genovese, Jeremy Geelan, Jamie Matusow

News Feed Item

Dr. David B. Samadi Says Talk About Prostate Cancer and Celebrate Life on Father's Day

NEW YORK, NY -- (Marketwire) -- 06/17/09 -- When you think of June, images of barbeques, sun and fun come to mind. It is also a month filled with weddings, graduations and new beginnings. According to the American Cancer Society, June is full of very important cancer awareness events such as Men's Health/Cancer Awareness Day on Father's Day, June 21. Dr. David B. Samadi, Chief of Robotics and Minimally Invasive Surgery at The Mount Sinai Medical Center, says this day is as good as any other to talk to the most important men in your life about prostate cancer screening and their health.

There is a reason why there are so many cancer awareness events in June, such as National Cancer Survivors Day (June 7) and National Men's Health Week (June 8-14). Prostate cancer is currently the second-leading cause of death in American men. According to the Prostate Cancer Foundation, more than 65% of all prostate cancers are diagnosed in men over the age of 65. But while it is true that a man's odds of developing prostate cancer increase exponentially with age, it is no longer an "old man's disease." Dr. Samadi treats patients as young as 39.

It is for precisely this reason that Dr. Samadi counsels earlier intervention as preventive medicine. Prostate care and routine screening tests, for example, prostate specific antigen (PSA), or digital rectal exam (DRE) tests, should be proactive when the prostate is normal and healthy. Of course eating healthy foods, regular exercise, maintaining proper body weight, and not smoking, are common sense recommendations for preventing prostate cancer. Samadi asks men to consider their family history because this is an important risk factor. Generally speaking, if someone had a close relative who was diagnosed with prostate cancer, they should be screened at the age of 40. If caught early enough, prostate cancer has a cure rate over 90%.

The best practice in fighting prostate cancer is not to wait until you have warning signs. Some patients may see blood in their semen or urine, or deal with urination problems. When the cancer has spread, it can manifest itself in bone and back pain, or compression of the spine. Also known as the "silent killer," once a patient has symptoms of prostate cancer, it can be too late, which is why frequent screenings are a must. What is important to keep in mind is that while prostate cancer is a serious health problem, it is not a death sentence. Dr. Samadi advises, "There is life after prostate cancer."

About David B. Samadi, MD

David B. Samadi, MD, is a board-certified urologic oncologist trained in open, laparoscopic, and robotic surgery. He is one of the world's most experienced da Vinci surgeons with a professionally acknowledged level of success. Dr. Samadi is one of the only surgeons in the country to have completed two fellowships: one in oncology at Memorial Sloan Kettering Cancer Center in New York, and the other in laparoscopy at Henri Mondor Hospital in France.

Dr. Samadi has completed more than 1,850 da Vinci cases in his career thus far. Since his arrival at The Mount Sinai Medical Center, Samadi has performed over 950 robotic operations. Dr. Samadi has proctored and taught urologists worldwide on how to perform the endopelvic fascia sparing robotic prostatectomy procedure. Dr. Samadi's robotic surgery program at Mount Sinai is unique in its ability to combine the advanced technology of robotics with the expertise of open and laparoscopic surgery.

To contact Dr. David Samadi, please call 1-888-Robot10 (1-888-762-6810), or visit his website: www.RoboticOncology.com.

Image Available: http://www2.marketwire.com/mw/frame_mw?attachid=1005630

Add to Digg Bookmark with del.icio.us Add to Newsvine

More Stories By Marketwired .

Copyright © 2009 Marketwired. All rights reserved. All the news releases provided by Marketwired are copyrighted. Any forms of copying other than an individual user's personal reference without express written permission is prohibited. Further distribution of these materials is strictly forbidden, including but not limited to, posting, emailing, faxing, archiving in a public database, redistributing via a computer network or in a printed form.